Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma

PDF  |  How to cite

Oncotarget. 2018; 9:36817-36817. https://doi.org/10.18632/oncotarget.26447

Metrics: PDF 1565 views  |   ?  

Davide Valentini1, Martin Rao2, Qingda Meng2, Anna von Landenberg2, Jiri Bartek Jr3,4, Georges Sinclair4, Georgia Paraschoudi2, Elke Jäger5, Inti Harvey-Peredo4, Ernest Dodoo4 and Markus Maeurer1,2,5

1 Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden
2 Therapeutic Immunology Unit (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden
3 Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
4 Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden
5 Krankenhaus Nordwest, Division of Oncology and Hematology, Frankfurt, Germany

Published: December 04, 2018

This article has been corrected: Please note the following IP filing: IP has been filed for the cytokine cocktail IL-2, IL-15 and IL-21 used for T-cell expansion.

Original article: Oncotarget. 2018; 9:19469-19480. DOI: https://doi.org/10.18632/oncotarget.24955.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26447